Markus S - Search Results

1

A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies.

Paik PK, Rudin CM, Brown A, Rizvi NA, Takebe N, Travis W, James L, Ginsberg MS, Juergens R, Markus S, Tyson L, Subzwari S, Kris MG, Krug LM. Paik PK, et al. Among authors: markus s. Cancer Chemother Pharmacol. 2010 Nov;66(6):1079-85. doi: 10.1007/s00280-010-1265-5. Epub 2010 Feb 18. Cancer Chemother Pharmacol. 2010. PMID: 20165849 Free PMC article. Clinical Trial.

2

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer.

Paik PK, Rudin CM, Pietanza MC, Brown A, Rizvi NA, Takebe N, Travis W, James L, Ginsberg MS, Juergens R, Markus S, Tyson L, Subzwari S, Kris MG, Krug LM. Paik PK, et al. Among authors: markus s. Lung Cancer. 2011 Dec;74(3):481-5. doi: 10.1016/j.lungcan.2011.05.005. Epub 2011 May 26. Lung Cancer. 2011. PMID: 21620511 Free PMC article. Clinical Trial.

3

Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen.

Wiernik PH, Dutcher JP, Paietta E, Gucalp R, Markus S, Weinberg V, Azar C, Garl S, Benson L. Wiernik PH, et al. Among authors: markus s. Leukemia. 1993 Aug;7(8):1236-41. Leukemia. 1993. PMID: 8350624

4

Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up.

Dutcher JP, Wiernik PH, Markus S, Weinberg V, Schiffer CA, Harwood KV. Dutcher JP, et al. Among authors: markus s. Leukemia. 1988 Jul;2(7):413-9. Leukemia. 1988. PMID: 3393023 Clinical Trial.

5

Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms.

Ostrow S, Egorin MJ, Hahn D, Markus S, Leroy A, Chang P, Klein M, Bachur NR, Wiernik PH. Ostrow S, et al. Among authors: markus s. Cancer. 1980 Oct 15;46(8):1715-21. doi: 10.1002/1097-0142(19801015)46:8<1715::aid-cncr2820460802>3.0.co;2-h. Cancer. 1980. PMID: 7191768

6

A clinical trial of pyrazofurin in combination with 5-azacytidine in acute adult nonlymphocytic leukemia.

Van Echo DA, Chiuten DF, Markus S, Wiernik PH. Van Echo DA, et al. Among authors: markus s. Cancer Clin Trials. 1981;4(2):129-33. Cancer Clin Trials. 1981. PMID: 6166406

7

Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia.

Esterhay RJ Jr, Wiernik PH, Grove WR, Markus SD, Wesley MN. Esterhay RJ Jr, et al. Among authors: markus sd. Blood. 1982 Feb;59(2):334-45. Blood. 1982. PMID: 7034815 Free article. Clinical Trial.

8

Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.

Van Echo DA, Markus S, Aisner J, Wiernik PH. Van Echo DA, et al. Among authors: markus s. Cancer Treat Rep. 1980 Aug-Sep;64(8-9):1009-10. Cancer Treat Rep. 1980. PMID: 6893810 No abstract available.

9

High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity.

Ostrow S, Egorin MJ, Hahn D, Markus S, Aisner J, Chang P, LeRoy A, Bachur NR, Wiernik PH. Ostrow S, et al. Among authors: markus s. Cancer Treat Rep. 1981 Jan-Feb;65(1-2):73-8. Cancer Treat Rep. 1981. PMID: 6784924 Clinical Trial.

10

Conserved roles for the dynein intermediate chain and Ndel1 in assembly and activation of dynein.

Okada K, Iyer BR, Lammers LG, Gutierrez PA, Li W, Markus SM, McKenney RJ. Okada K, et al. Among authors: markus sm. Nat Commun. 2023 Sep 20;14(1):5833. doi: 10.1038/s41467-023-41466-5. Nat Commun. 2023. PMID: 37730751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page